Intro Pullout Text Widget

Lupus Science & Medicine®

is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.

Impact Factor: 4.687
Citescore: 5.6
All metrics >>

Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases.

An official journal of the Lupus Foundation of America (LFA), which is dedicated to advancing the science and medicine of lupus while offering support to patients and their caregivers.

Follow the journal via Twitter and Facebook.

Editors-in-Chief: Professor Jill Buyon, New York University, USA and Professor Ronald van Vollenhoven, Amsterdam University Medical Centers, The Netherlands
Editorial team

Current Issue

Publish in LSM

Lupus Science & Medicine considers submissions of a range of article types, including original research, brief communications, study protocols and meeting reports.

Information is also provided on editorial policies and open access.

This is an open access journal that levies an Article Publishing Charge (APC). Discounts and waivers are available; details are provided in the Author Information section.

All manuscripts should be submitted online.

Published articles are discoverable via PubMed, Web of Science, Scopus and Google Scholar.

Video: Benefits of publishing in Lupus Science & Medicine

Author information

Submit a paper

Lupus & KCR 2023

Lupus Science & Medicine is delighted to be the official journal of Lupus & KCR 2023, which will be held in Seoul in May 2023.

Abstract submission is open until 2nd December 2022. The abstracts from the conference will be published online in a supplement to Lupus Science & Medicine.

Intro Pullout Text Widget

Lupus Science & Medicine®

Publish in LSM

Latest Articles

Epidemiology and outcomes:

Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study

Immunology and inflammation:

Molecular endotypes of type 1 and type 2 SLE

Lupus nephritis:

Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis

Letter:

Consequences of medication unavailability on patient anxiety: the example of the 2020 hydroxychloroquine availability crisis for patients with SLE – 18 months later

Lupus nephritis:

Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials

Lupus & KCR 2023

LSM Podcasts

Most Read Articles

Epidemiology and outcomes:

Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study

Brief communication:

Black patients with cutaneous lupus are associated with positive family history of cutaneous lupus and systemic lupus

Review:

Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria

Epidemiology and outcomes:

Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine

Review:

Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology

Featured Video

Lupus Science & Medicine

Altmetrics

Twitter Feed

Related Journals